NASA developed osteoporosis test to detect bone loss early

Earlier detection of bone loss may be in future — NASA-funded research looks to isotope analysis rather than X-ray for measurement – A more sensitive technique is developed by scientists at Arizona State University and NASA for detecting bone loss early than the X-ray method used today, with less risk to patients.

IMRT Radiation optimal for localized prostate cancer

Intensity Modulated Radiation Therapy optimal for localized prostate cancer – A treatment for localized prostate cancer known as Intensity Modulated Radiation Therapy (IMRT) is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence.

New technique for screening breast cancer using ultrasound

New screening technique could provide more reliable breast cancer detection — Initial tests show promising results of new ultrasonic screening technique – Scientists have successfully completed an initial trial of a new, potentially more reliable, technique for screening breast cancer using ultrasound. The team at the National Physical Laboratory (NPL), the UK’s National Measurement Institute, working with the University Hospitals Bristol NHS Foundation Trust, are now looking to develop the technique into a clinical device.

Erivedge approved for skin cancer metastatic basal cell carcinoma

FDA approves new treatment for most common type of skin cancer – Erivedge or vismodegib was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The Erivedge drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has spread to other parts of the body (metastatic).

Breast cancer survivors may experience mental abilities problems

Breast cancer survivors struggle with cognitive problems several years after treatment – Breast cancer survivors may experience problems with certain mental abilities several years after breast cancer treatment, regardless of whether they were treated with breast cancer chemotherapy plus radiation or radiation for breast cancer only.

Financial reimbursement increases cardiac stress tests in patients

Cardiac stress imaging more frequent among patients whose physicians provide, bill for procedures – Financial reimbursement and ownership of cardiac imaging equipment appears to influence physicians’ use of cardiac stress testing. The study finds that doctors who are reimbursed for both performing the test using their equipment and then interpreting the results were 50 to 100 percent more likely to order cardiac imaging tests on their patients than those who don’t bill the fees.

Tanning bed ban for minors under 18 in California US

Tanning bed ban for minors under 18 in California US – Teens and owners object to tanning-bed ban – California toughens teen tanning laws – California Governor Edmund G. Brown, Jr., signed groundbreaking legislation today that will prohibit the use of commercial indoor tanning devices for those under the age of 18. California is the first state to ban minors from using commercial tanning booths.

More aggressive treatment not necessary for men with a family history of prostate cancer

More aggressive treatment not necessary for men with a family history of prostate cancer – Approximately 10-20 percent of prostate cancer patients have a family history of the disease. There are three major factors that are used to evaluate the extent and aggressiveness of prostate cancer, help make treatment decisions, and estimate prognosis: the Prostate Specific Antigen Level (PSA), Gleason score (GS) from the biopsy, and the digital rectal exam findings (DRE).

$3.5 million Komen award to study rare and aggressive type of breast cancer

TGen breast cancer research benefits from $3.5 million Komen award — Grant enables multi-institute team to study rare and aggressive type of breast cancer – The Translational Genomics Research Institute (TGen) is part of a team of medical investigators receiving a $3.5 million grant from Susan G. Komen for the Cure to study triple-negative breast cancer, a highly aggressive form of this cancer that disproportionately affects African-Americans.

Health Newstrack